April 2023
HCD Economics would like to say a big thank you to everyone that has helped us with our CHESS studies on World Haemophilia Day
For several years HCD Economics has keenly watched gene therapy developments in Haemophilia and in 2022 the first two gene therapies, for Haemophilia A & B, were granted marketing authorisation by both the EMA & FDA.
Read More